146 related articles for article (PubMed ID: 18725905)
21. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
[TBL] [Abstract][Full Text] [Related]
22. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
23. Atypical diabetes mellitus in children - when to suspect drug-induced diabetes. A case-based review of the literature.
A Okruszko M; Szabłowski M; Pochodowicz K; Taranta-Janusz K; Bossowski A; Głowińska-Olszewska B
Pediatr Endocrinol Diabetes Metab; 2022; 28(4):294-300. PubMed ID: 36106423
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
[TBL] [Abstract][Full Text] [Related]
25. [Characteristics of newly diagnosed diabetes patients with young onset in the West China Hospital of Sichuan University].
Gong Y; Che TT; Liu SF; Ren Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):524-8. PubMed ID: 24941832
[TBL] [Abstract][Full Text] [Related]
26. [Mature onset diabetes of the young (MODY)].
Nobre EL; Lopes LO; Miranda A; Pragosa M; de Castro JJ
Acta Med Port; 2002; 15(6):435-9. PubMed ID: 12680290
[TBL] [Abstract][Full Text] [Related]
27. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
28. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
29. DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
Vellanki P; Umpierrez GE
Endocr Pract; 2017 Aug; 23(8):971-978. PubMed ID: 28534682
[TBL] [Abstract][Full Text] [Related]
30. [Factors involved in ketoacidosis at the onset of type 1 diabetes in childhood].
Młynarski W; Zmysłowska A; Kubryn I; Perenc M; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):23-8. PubMed ID: 12831634
[TBL] [Abstract][Full Text] [Related]
31. Latent Autoimmune Diabetes in Adults: a case report.
Bermúdez V; Aparicio D; Colmenares C; Peñaranda L; Luti Y; Gotera D; Rojas J; Cabrera M; Reyna N; Velasco M; Israili ZH
Am J Ther; 2010; 17(3):284-7. PubMed ID: 20224323
[TBL] [Abstract][Full Text] [Related]
32. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China.
Yang L; Yang G; Li X
BMC Endocr Disord; 2021 Jun; 21(1):131. PubMed ID: 34176476
[TBL] [Abstract][Full Text] [Related]
33. A rare case of a mother with gestational diabetes complicated with fulminant type 1 diabetes mellitus post-delivery.
Ting Tai Y; Mohd Noor N
J R Coll Physicians Edinb; 2022 Jun; 52(2):120-123. PubMed ID: 36147001
[TBL] [Abstract][Full Text] [Related]
34. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
Umpierrez GE; Clark WS; Steen MT
Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
[TBL] [Abstract][Full Text] [Related]
35. [Fulminant type 1 diabetes in an elderly patient treated after receiving a diagnosis of type 2 diabetes].
Ogawa A; Niiya T; Manabe K; Kawamoto E
Nihon Ronen Igakkai Zasshi; 2013; 50(6):818-23. PubMed ID: 24622231
[TBL] [Abstract][Full Text] [Related]
36. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.
Umpaichitra V; Banerji MA; Castells S
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):853-64. PubMed ID: 15270403
[TBL] [Abstract][Full Text] [Related]
37. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up.
Pitteloud N; Philippe J
Schweiz Med Wochenschr; 2000 Apr; 130(16):576-82. PubMed ID: 10842773
[TBL] [Abstract][Full Text] [Related]
39. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
40. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
